As Anthropic heads towards a $2 trillion IPO, some of the loudest critics are company insiders

Anthropic is reportedly preparing a record $2 trillion IPO, but current and former researchers have publicly warned that advanced AI could pose existential risks; Alignment Science lead Evan Hubinger estimates a greater than 10% chance AI kills all humans within a decade. SOC Investment Group has called for Anthropic to delay its offering, arguing that its June confidential filing preceded recent hacking incidents, safety warnings and proposals to slow AI development, limiting investors’ ability to price the risks. The disclosures could weigh on IPO demand and valuation, although public-market scrutiny and safety commitments could also be positioned as commercial strengths.

Analysis

The investable issue is not whether existential-risk claims are correct; it is whether they convert into a measurable commercialization constraint. A public AI developer that voluntarily slows model releases, limits high-risk deployments, or absorbs materially higher evaluation and compliance costs will face a lower revenue-growth ceiling and weaker operating leverage than private-market valuation frameworks imply. The first-order beneficiary is the enterprise AI stack: customers seeking durable, auditable deployment will shift spend toward infrastructure, governance, security, and model-orchestration vendors rather than concentrate budgets in a single frontier-model provider.

Near term, the signal raises IPO execution risk: a delayed filing, expanded risk disclosures, employee-retention provisions, governance concessions, or a valuation discount would reset private AI comparables and could pressure listed AI-adjacent names whose multiples embed uninterrupted model scaling. Over 1-3 months, the relevant catalyst is the registration statement: disclosed revenue concentration, inference gross margins, cloud-compute commitments, related-party arrangements, safety-triggered deployment restrictions, and dual-class/control terms matter far more than public employee commentary. A credible third-party assurance regime would be a positive for enterprise adoption but could also create a compliance moat favoring capitalized incumbents.

Contrarian view: alarmist messaging may strengthen commercial positioning rather than impair it. Regulated buyers value auditability, indemnification, data controls, and predictable model behavior; if safety positioning wins large financial-services, healthcare, or government workloads, higher compliance expense can be offset by lower churn and premium pricing. The thesis fails if customers demonstrate that safety constraints do not influence vendor selection, or if open-weight models reach comparable capability at materially lower cost and commoditize frontier-model pricing over the next 6-18 months.

Key Decisions for Investors

• No directional pre-IPO position: wait for the S-1 before underwriting valuation or governance risk. Build a diligence checklist around revenue concentration, cloud minimum-spend obligations, stock-based compensation, model-release restrictions, and any safety committee veto rights; these inputs determine whether a reported growth rate is economically durable.
• Overweight enterprise AI governance and cybersecurity exposure versus pure model-valuation beta over the next 6-12 months: consider a basket led by PANW, CRWD, MSFT and NOW. Risk/reward improves if disclosure-driven regulation raises required monitoring and identity-control spend; reduce if AI application adoption remains pilot-heavy and security budgets fail to reaccelerate.
• Use any IPO-related risk-off move in MSFT as a relative-value opportunity rather than a structural short. Azure benefits if enterprises diversify model access and demand managed, compliant deployment; falsify on sustained Azure growth deceleration or evidence that inference economics materially dilute cloud margins.
• Set an alert for a delayed offering, formal regulatory investigation, or disclosed deployment pause. Those events would justify reassessing AI infrastructure exposure, especially NVDA and data-center supply-chain beta, because the key downside transmission is lower frontier-model training cadence and deferred capex—not reputational risk alone.